Cargando…
Cytarabine preferentially induces mutation at specific sequences in the genome which are identifiable in relapsed acute myeloid leukaemia
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320285/ https://www.ncbi.nlm.nih.gov/pubmed/25249014 http://dx.doi.org/10.1038/leu.2014.284 |
_version_ | 1782356098759524352 |
---|---|
author | Fordham, S E Cole, M Irving, J A Allan, J M |
author_facet | Fordham, S E Cole, M Irving, J A Allan, J M |
author_sort | Fordham, S E |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4320285 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-43202852015-02-17 Cytarabine preferentially induces mutation at specific sequences in the genome which are identifiable in relapsed acute myeloid leukaemia Fordham, S E Cole, M Irving, J A Allan, J M Leukemia Letter to the Editor Nature Publishing Group 2015-02 2014-10-17 /pmc/articles/PMC4320285/ /pubmed/25249014 http://dx.doi.org/10.1038/leu.2014.284 Text en Copyright © 2015 Macmillan Publishers Limited http://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ |
spellingShingle | Letter to the Editor Fordham, S E Cole, M Irving, J A Allan, J M Cytarabine preferentially induces mutation at specific sequences in the genome which are identifiable in relapsed acute myeloid leukaemia |
title | Cytarabine preferentially induces mutation at specific sequences in the genome which are identifiable in relapsed acute myeloid leukaemia |
title_full | Cytarabine preferentially induces mutation at specific sequences in the genome which are identifiable in relapsed acute myeloid leukaemia |
title_fullStr | Cytarabine preferentially induces mutation at specific sequences in the genome which are identifiable in relapsed acute myeloid leukaemia |
title_full_unstemmed | Cytarabine preferentially induces mutation at specific sequences in the genome which are identifiable in relapsed acute myeloid leukaemia |
title_short | Cytarabine preferentially induces mutation at specific sequences in the genome which are identifiable in relapsed acute myeloid leukaemia |
title_sort | cytarabine preferentially induces mutation at specific sequences in the genome which are identifiable in relapsed acute myeloid leukaemia |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320285/ https://www.ncbi.nlm.nih.gov/pubmed/25249014 http://dx.doi.org/10.1038/leu.2014.284 |
work_keys_str_mv | AT fordhamse cytarabinepreferentiallyinducesmutationatspecificsequencesinthegenomewhichareidentifiableinrelapsedacutemyeloidleukaemia AT colem cytarabinepreferentiallyinducesmutationatspecificsequencesinthegenomewhichareidentifiableinrelapsedacutemyeloidleukaemia AT irvingja cytarabinepreferentiallyinducesmutationatspecificsequencesinthegenomewhichareidentifiableinrelapsedacutemyeloidleukaemia AT allanjm cytarabinepreferentiallyinducesmutationatspecificsequencesinthegenomewhichareidentifiableinrelapsedacutemyeloidleukaemia |